Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
about
Is fat taste ready for primetime?The thrifty lipids: endocannabinoids and the neural control of energy conservationEffects of fatty acid treatments on the dexamethasone-induced intramuscular lipid accumulation in chickensRegulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cellsThe atypical cannabinoid O-1602 stimulates food intake and adiposity in rats.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Nonhuman primates and other animal models in diabetes research.The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat.Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemiaCentral endocannabinoid signaling regulates hepatic glucose production and systemic lipolysisEffects of Chronic Antagonism of Endocannabinoid-1 Receptors on Glucose Tolerance and Insulin Action in Skeletal Muscles of Lean and Obese Zucker Rats.Caenorhabditis Elegans Mutants Predict Regulation of Fatty Acids and Endocannabinoids by the CYP-35A Gene Family.CB(1) cannabinoid receptors and their associated proteins.Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity.Does rimonabant independently affect free fatty acid and glucose metabolism?Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor DiabeticCannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility.The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesityVariants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart diseaseEffects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.GLP-1R agonism enhances adjustable gastric banding in diet-induced obese ratsCannabis use and obesity and young adults.The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.Metabolic syndrome in people with a psychotic illness: is cannabis protective?Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice.Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot study.Effects of chronic oral rimonabant administration on energy budgets of diet-induced obese C57BL/6 mice.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Obesity Drug Update: The Lost Decade?Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight.The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential.Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.
P2860
Q22337316-AE082D90-F038-4441-B881-2C83362E7A21Q26996134-FB68D2AA-5A15-4AA8-9DEA-05D027B00FBBQ27303384-C2C0C942-5DE3-4090-AD73-D6A0A75DAFE1Q33604478-6FD73D2C-AC23-48DE-9B1E-F52C560E9FA8Q34222264-B132CC24-0E83-423C-87ED-C3EBB9417266Q34274859-ED57A605-377E-407B-BD16-DA6D562070EDQ34286456-DCC99E70-222F-4AEF-8923-8FFE0E40B0ABQ34504906-CE2C414D-5F6C-4FE7-AA1F-7545ABA725EFQ34581048-5CB18D68-1E2B-4EEC-ABAF-A94DF2AB54F7Q34718604-6DA806E3-A477-4BB6-BC1B-3E442C6EB271Q35005385-F73D2642-CD30-4D80-87AB-3C594A51DA25Q35026072-C18A3B84-D6FA-4A2D-9088-0F54363DA75DQ35232109-20D7A405-4C87-4A6F-8B50-E53511991570Q35738935-482BCDBC-4115-4C47-A7C8-A2153BFE2764Q35869688-66F95870-D80B-4428-97C8-B9E32D3EF3C5Q36097577-CD6CA246-91E4-496C-ADE7-CA19988A0237Q36721060-1B40BC7B-A5D3-4A54-BC43-BCD5053D4100Q36900366-585ECC77-15D5-4D3B-837E-C7D78A5C564EQ36940105-287F5692-2D69-4980-82D8-E34B0842CAD7Q37029513-42431E62-B40B-4216-899D-874F18ED14CCQ37110510-31AAFAA0-D4C8-4062-9477-D469791E2342Q37799380-FEFE3645-0B58-49B3-A53E-7619AE7BA742Q37913717-F4D821E6-CDD4-4D02-855E-1F2BD58729F4Q39930298-A08B3875-2AF6-4F3C-AB13-BBB173BACFD1Q42823729-54CC4314-9FC2-4DBB-B426-262451EE396EQ43238409-0F0C2715-ABEE-4EFB-B199-9157144D76D5Q43445796-EC4EAA38-7D69-4AE2-A244-51C212B95368Q45288843-7E284FC8-57BA-4466-8CCE-3EDA7964EC18Q46972562-782801B3-AB72-4BDB-BC06-48A942E8D8CAQ47099002-82DCEF4A-A4FE-4183-956D-A65748484245Q47330379-3F00069A-84A3-4C4B-94F3-A1C3CD287A50Q50592444-07B2BBD2-65A8-461D-B592-BF3846C4565CQ54611166-7BFF2D73-FCC9-469E-A2D0-C602BEE7AE8F
P2860
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
description
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
scientific journal article
@en
vedecký článok (publikovaný 2009/08/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/08/01)
@nl
наукова стаття, опублікована в серпні 2009
@uk
مقالة علمية (نشرت في أغسطس 2009)
@ar
name
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@ast
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@en
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@nl
type
label
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@ast
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@en
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@nl
prefLabel
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@ast
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@en
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@nl
P2093
P2860
P3181
P356
P1433
P1476
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism
@en
P2093
Darleen A Sandoval
David A D'Alessio
Elena Prodi
Massimiliano Olivieri
Silvana Obici
Stephen C Woods
P2860
P304
P3181
P356
10.1038/OBY.2009.84
P577
2009-03-26T00:00:00Z